GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Adimmune 4142.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

16.70

+2.14%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.40bn

FY2016FY2025

Net income

−TWD 239.9m

FY2016FY2025

Free cash flow

−TWD 242.2m

FY2016FY2025

Shareholders' equity

TWD 4.94bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.40bnTWD 1.56bnTWD 1.79bnTWD 2.25bnTWD 1.64bnTWD 1.87bnTWD 1.30bnTWD 822.4mTWD 562.7mTWD 606.7m
Research and developmentTWD 237.4mTWD 292.0mTWD 296.9mTWD 346.4mTWD 321.3mTWD 337.7mTWD 235.6mTWD 205.9mTWD 222.3mTWD 164.7m
Operating income−TWD 359.6m−TWD 320.0m−TWD 736.6mTWD 98.6mTWD 29.0mTWD 1.22bn−TWD 273.5m−TWD 725.2m−TWD 737.7m−TWD 594.0m
Net income−TWD 239.9m−TWD 242.8m−TWD 639.9mTWD 291.0mTWD 43.1mTWD 1.24bn−TWD 280.7m−TWD 617.8m−TWD 760.2m−TWD 595.4m
Diluted earnings per share-0.57-0.58-1.520.690.102.94-0.79-2.92-3.09-2.41

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 8.19bnTWD 8.48bnTWD 9.48bnTWD 9.15bnTWD 8.01bnTWD 8.47bnTWD 6.57bnTWD 5.68bnTWD 5.75bnTWD 6.78bn
Cash and short-term investmentsTWD 2.24bnTWD 2.47bnTWD 2.49bnTWD 2.97bnTWD 2.89bnTWD 4.44bnTWD 1.11bnTWD 648.7mTWD 1.24bnTWD 1.67bn
Total liabilitiesTWD 3.14bnTWD 2.92bnTWD 3.71bnTWD 2.60bnTWD 1.58bnTWD 1.84bnTWD 2.74bnTWD 3.82bnTWD 3.40bnTWD 3.69bn
DebtTWD 2.78bnTWD 2.60bnTWD 3.14bnTWD 2.26bnTWD 1.32bnTWD 1.32bnTWD 2.61bnTWD 3.56bnTWD 3.10bnTWD 3.49bn
Shareholders' equityTWD 4.94bnTWD 5.23bnTWD 5.47bnTWD 6.12bnTWD 6.15bnTWD 6.32bnTWD 3.65bnTWD 1.64bnTWD 2.11bnTWD 2.88bn
Shares outstanding421m422m422m424m427m422m357m211m246m247m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 5.4mTWD 668.5m−TWD 892.3m−TWD 292.0m−TWD 480.5mTWD 2.32bn−TWD 252.7m−TWD 601.7mTWD 6.9m−TWD 773.5m
Capital spending−TWD 236.7m−TWD 155.2m−TWD 221.5m−TWD 419.6m−TWD 845.3m−TWD 218.3m−TWD 55.7m−TWD 22.7m−TWD 11.3m−TWD 19.4m
Free cash flow−TWD 242.2mTWD 513.3m−TWD 1.11bn−TWD 711.6m−TWD 1.33bnTWD 2.10bn−TWD 308.5m−TWD 624.4m−TWD 4.5m−TWD 792.9m
Dividends paid————−TWD 214.8m−TWD 214.8m−TWD 214.8m−TWD 214.8m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 66.8mTWD 82.3mTWD 745.5mTWD 475.3mTWD 108.6mTWD 72.1mTWD 545.1mTWD 888.2m
Operating income−TWD 172.7m−TWD 199.2mTWD 150.2m−TWD 50.0m−TWD 208.3m−TWD 264.9m−TWD 80.3mTWD 268.7m
Net income−TWD 160.2m−TWD 185.5mTWD 130.5m−TWD 18.3m−TWD 218.8m−TWD 223.3m−TWD 48.3mTWD 263.3m
Diluted earnings per share-0.38-0.440.31-0.04-0.52-0.53-0.110.62
Cash from operations−TWD 316.0m−TWD 219.0mTWD 826.0m−TWD 355.0m−TWD 265.0m−TWD 211.0mTWD 658.0m−TWD 301.0m
Capital spending−TWD 25.0m−TWD 58.0m−TWD 56.0m−TWD 58.0m−TWD 1.0m−TWD 119.0m−TWD 42.0m−TWD 22.0m
Free cash flow−TWD 341.0m−TWD 277.0mTWD 770.0m−TWD 413.0m−TWD 266.0m−TWD 330.0mTWD 616.0m−TWD 323.0m
Total assetsTWD 8.11bnTWD 7.82bnTWD 8.19bnTWD 8.38bnTWD 8.27bnTWD 8.33bnTWD 8.48bnTWD 8.62bn
Cash and short-term investmentsTWD 1.82bnTWD 1.84bnTWD 2.24bnTWD 1.81bnTWD 1.93bnTWD 2.16bnTWD 2.47bnTWD 1.86bn
DebtTWD 337.5mTWD 2.68bnTWD 2.78bnTWD 3.22bnTWD 2.81bnTWD 2.67bnTWD 2.54bnTWD 2.57bn
Shareholders' equityTWD 4.62bnTWD 4.76bnTWD 4.94bnTWD 4.73bnTWD 4.76bnTWD 5.00bnTWD 5.23bnTWD 5.30bn

Financial ratios

Data as of 9 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-25.7%-19.3%-41.3%7.9%1.8%65.2%
Net margin-17.1%-15.6%-35.8%12.9%2.6%66.4%
Return on equity-4.9%-4.6%-11.7%4.8%0.7%19.7%
Return on assets-2.9%-2.9%-6.7%3.2%0.5%14.6%
Free cash flow yield2.9%10.2%-8.3%1.6%4.5%31.4%
Revenue growth-10.0%-12.8%-20.7%37.2%-12.2%43.8%
Earnings growth-1.2%-62.1%-319.9%575.6%-96.5%-542.2%
Current ratio2.12x3.11x2.63x8.97x12.78x9.61x
Debt to equity0.56x0.49x0.57x0.36x0.21x0.21x
Equity ratio60.4%61.7%57.7%66.9%76.8%74.5%
Interest coverage-11.54x-8.22x-22.04x7.91x1.97x55.02x
R&D as a share of sales16.9%18.8%16.6%15.4%19.6%18.1%
Buybacks as a share of market value0.2%0.0%0.6%0.6%-1.1%-18.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-14.6%-5.6%17.0%
Operating income——-6.9%
Net income——-10.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-23.0%-18.8%-0.7%-22.3%
Net margin-16.3%-11.9%4.3%-18.2%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-33.3-34.9-21.851.9442.319.1-32.1-6.5-6.2-8.9
Price to sales5.75.47.86.711.612.76.94.98.38.8

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 14 Sept 2021.

FY2021
Paid in the year0.50

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.